Demographic and clinical data of IPA and non-IPA patients.

Abbreviations: NS, non-significant. HSCT: Hematopoietic stem cell transplantation, AML: acute myeloid leukemia, ALL: acute lymphoid leukemia, MM: Multiple Myeloma, CML: chronic myeloid leukemia, HL: Hodgekin's lymphoma, NHL: non-Hodgekin's lymphoma, AA: Aplastic anemia, CLL: chronic lymphocytic leukemia, MDS: myelodysplastic syndrome.†: Severe neutropenia was defined as absolute neutrophil count 3 for a period of more than 12 days. GVHD: graft versus host disease;‡: p-values were calculated by student-t test for continous- and Fishers exact test for binary data.

缩略语说明：
NS：无统计学意义（non-significant）；
HSCT：造血干细胞移植（Hematopoietic stem cell transplantation）；
AML：急性髓系白血病（acute myeloid leukemia）；
ALL：急性淋巴细胞白血病（acute lymphoid leukemia）；
MM：多发性骨髓瘤（Multiple Myeloma）；
CML：慢性髓系白血病（chronic myeloid leukemia）；
HL：霍奇金淋巴瘤（Hodgkin's lymphoma，原文原拼写为Hodgekin's lymphoma，采用标准医学译法）；
NHL：非霍奇金淋巴瘤（non-Hodgkin's lymphoma）；
AA：再生障碍性贫血（Aplastic anemia）；
CLL：慢性淋巴细胞白血病（chronic lymphocytic leukemia）；
MDS：骨髓增生异常综合征（myelodysplastic syndrome）。
†：重度中性粒细胞减少症定义为绝对中性粒细胞计数为3且持续时长超过12天。
GVHD：移植物抗宿主病（graft versus host disease）；
‡：连续型数据采用t检验计算P值，二分类数据采用Fisher精确检验计算P值。